David A. Siegel Incyte Corp Transaction History
Two Sigma Advisers, LP
- $47 Billion
- Q3 2025
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Incyte Corp stock. As of the latest transaction made, Two Sigma Advisers, LP holds 7,800 shares of INCY stock, worth $812,370. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,800
Previous 7,200
8.33%
Holding current value
$812,370
Previous $490,000
34.9%
% of portfolio
0.0%
Previous 0.0%
Shares
31 transactions
Others Institutions Holding INCY
# of Institutions
795Shares Held
205MCall Options Held
638KPut Options Held
635K-
Baker Bros. Advisors LP New York, NY30.7MShares$3.2 Billion21.24% of portfolio
-
Black Rock Inc. New York, NY21.4MShares$2.22 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA20MShares$2.08 Billion0.03% of portfolio
-
Dodge & Cox San Francisco, CA13.9MShares$1.45 Billion0.68% of portfolio
-
State Street Corp Boston, MA9.68MShares$1.01 Billion0.03% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $23.2B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...